These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3059763)

  • 1. Cutaneous leishmaniasis: relative role of T cell subsets.
    Titus R; Marchand M; Milon G; Marchal G; Boon T; Louis J
    Adv Exp Med Biol; 1988; 239():121-34. PubMed ID: 3059763
    [No Abstract]   [Full Text] [Related]  

  • 2. Subsets of specific T cells and experimental cutaneous leishmaniasis.
    Louis JA; Pedrazzini T; Titus RG; Muller I; Farrell JP; Kindler V; Vassalli P; Marchal G; Milon G
    Ann Inst Pasteur Immunol; 1987; 138(5):755-8. PubMed ID: 3501956
    [No Abstract]   [Full Text] [Related]  

  • 3. Attempts to assess the contribution of T lymphocytes from the L3T4+ and LYT2+ subsets in the immunological control of cutaneous leishmaniasis.
    Louis JA; Titus RG; Mendonca SC; Marchal G; Milon G
    Lepr Rev; 1986 Dec; 57 Suppl 2():255-61. PubMed ID: 3106738
    [No Abstract]   [Full Text] [Related]  

  • 4. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells.
    Moll H; Scollay R; Mitchell GF
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():57-63. PubMed ID: 3259538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice.
    Farrell JP; Muller I; Louis JA
    J Immunol; 1989 Mar; 142(6):2052-6. PubMed ID: 2784148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The T cell phenotypes in the lesion of patients with cutaneous leishmaniasis.
    Huszar M; Shor R; Trau H; Gazit E; Passwell JH
    Clin Exp Dermatol; 1987 Mar; 12(2):103-7. PubMed ID: 3500000
    [No Abstract]   [Full Text] [Related]  

  • 8. On immunobiology of experimental leishmaniasis.
    Kaye PM; Roberts MB; Blackwell JM
    Ann Inst Pasteur Immunol; 1987; 138(6):907. PubMed ID: 3502451
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4+ T cell subsets in experimental cutaneous leishmaniasis.
    Scott P; Natovitz P; Coffman RL; Pearce E; Sher A
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():256-9. PubMed ID: 3267029
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetically determined response mechanisms to cutaneous leishmaniasis.
    Howard JG; Hale C; Liew FY
    Trans R Soc Trop Med Hyg; 1982; 76(2):152-4. PubMed ID: 6980502
    [No Abstract]   [Full Text] [Related]  

  • 11. T-cell responses during infections with Leishmania major.
    Müller I; Milon G; Louis J
    Behring Inst Mitt; 1991 Feb; (88):80-3. PubMed ID: 1904711
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indices of the state of the T-system of immunity in experimental cutaneous leishmaniasis in guinea pigs].
    Konovalova SA
    Med Parazitol (Mosk); 1981; 50(6):23-7. PubMed ID: 6976505
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis.
    Titus RG; Milon G; Marchal G; Vassalli P; Cerottini JC; Louis JA
    Eur J Immunol; 1987 Oct; 17(10):1429-33. PubMed ID: 3119350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice.
    McElrath MJ; Kaplan G; Nusrat A; Cohn ZA
    J Exp Med; 1987 Feb; 165(2):546-59. PubMed ID: 3546576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis.
    Antonelli LR; Dutra WO; Oliveira RR; Torres KC; Guimarães LH; Bacellar O; Gollob KJ
    Infect Immun; 2006 Nov; 74(11):6317-23. PubMed ID: 16923794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
    Sypek JP; Panosian CB; Wyler DJ
    J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of leishmaniasis: an update.
    Mansueto P; Vitale G; Di Lorenzo G; Rini GB; Mansueto S; Cillari E
    Int J Immunopathol Pharmacol; 2007; 20(3):435-45. PubMed ID: 17880757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal B-cell stimulation by T-cells in a parasitic disease.
    Lohoff M; Koch A; Röllinghoff M
    Behring Inst Mitt; 1991 Feb; (88):84-93. PubMed ID: 2049049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.
    Titus RG; Ceredig R; Cerottini JC; Louis JA
    J Immunol; 1985 Sep; 135(3):2108-14. PubMed ID: 3926895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.